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METHODS: A retrospective analysis of the 1996 portion
of the Medical Expenditure Panel Survey (MEPS) was
conducted. The MEPS provided data from a nationally
representative sample of 22,601 respondents and data
from respondent’s medical care and health-insurance
providers and employers. Data included medical condi-
tions and employment information comprised of hourly
earnings, hours worked, and disability days. Back pain
patients who incurred disability days were identified us-
ing International Classification of Diseases (ICD-9-CM)
codes determined by an expert panel of physicians and
coders as indicative of back pain and variables denoting
disability days. Indirect costs were calculated for back
pain patients who missed workdays using the human
capital approach. Sample estimates were weighted and
projected to the population and 95 percent confidence in-
tervals for estimates were calculated using the Taylor ex-
pansion method.
RESULTS: Total indirect costs for back pain patients
who missed workdays were $18,533,583,620. Mean in-
direct costs were $4586 per back pain patient who
missed workdays (95% CI  $3852 to $5321). Relative
to the entire population, the mean indirect costs were
$68.92 per person.
CONCLUSIONS: With losses in productivity greater than
$18.5 billion, indirect costs significantly contribute to the
total cost of back pain. The indirect costs of back pain to
labor underscore the need to prevent back injury thereby
promoting employee health and maintaining productivity.
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OBJECTIVES: To assess the influence of depression, de-
mentia and disease severity on the health-related quality
of life in Parkinson’s disease (PD).
METHODS: Health-related quality of life was assessed
in 91 patients with PD (male: 62; female: 29; mean age:
67  9) using the Parkinson’s disease questionnaire
(PDQ-39) and the Parkinson’s disease Quality of life
questionnaire (PDQL). Dementia was evaluated by using
the MMSE and depression was rated with the Beck’s De-
pression Inventory (BDI). Disease severity and motor dys-
function were recorded with the Hoehn and Yahr scale
and the UPDRS II-IV. Pearson’s correlation coefficient
was used to calculate correlation scores.
RESULTS: Both specific disease QoL rating scales corre-
lated with depressive symptoms (r  0.73, p  .0001).
UPDRS III (r  0.69, p  .0001) and HY stage (r  0.59,
p  .001) also correlated with decreased QoL. However,
motor fluctuations and dyskinesias had a minor impact
on QoL (r  0.40, p  .001). Dementia or cognitive im-
pairment had a minor correlation with QoL (r  0.30, p 
.001).
CONCLUSIONS: We found a high correlation between
QoL and depression by using PDQ-39 and PDQL. In
contrast, a minor correlation was observed between
MMSE scores and health-related QoL. Treating depres-
sive symptoms in PD patients may considerably improve
their quality of life.
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OBJECTIVE: 25% to 30% of patients with Parkinson’s
disease treated with levodopa present motor complica-
tions after three years. The health-care consumption by
patients with these symptoms is roughly twice as high as
the costs for patients without them. A clinical trial com-
paring cabergoline (with the possibility if adding levodopa
if needed) to levodopa has shown that the use of caber-
goline delays the onset of motor complications. The pur-
pose of this study is to compare the cost-effectiveness of
the two treatment strategies in a Swedish setting.
METHODS: A Markov model was constructed with
states based on the Hoehn and Yahr (HY) stages with an
additional stage for patients with complications. Transi-
tion probabilities between the HY stages were calculated
from the clinical trial data using ordered probit regres-
sion, while the probability of developing complications
was based on the frequency of this event at each time
point in the trial. Direct costs were derived from a Swed-
ish observational study. Years-of-complications-avoided
was used as the measure of effectiveness in this analysis.
RESULTS: The incremental cost-effectiveness ratio for
cabergoline was 4000 USD per year of motor complica-
tions avoided. Inclusion of indirect costs would influence
the results in younger patients. The literature suggests
that the costs of indirect care would decrease the cost-ef-
fectiveness ratio, so that the number reported here may
represent an overestimate of the total cost of preventing
motor complications.
CONCLUSION: Based on our data, Cabergoline was
found to represent a cost-effective means for reducing the
impact of motor dysfunction if the willingness to pay ex-
ceeds 4000 USD per year of motor complications avoided.
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OBJECTIVE: To develop two comorbidity indexes con-
structed from the Minimum Dataset (MDS) disease infor-
mation predictive of 18-month mortality and 2 hospi-
talizations in a prevalence cohort of 1424 white, female
nursing-home residents that could be used as part of a
risk adjustment method for quality-of-care outcomes.
METHODS: A split-sample approach was taken for de-
velopment and cross validation of the indexes. Multivari-
ate logistic regression techniques were employed to iden-
tify the MDS diseases most likely to predict each outcome
after controlling for age in the development sample.
Weights equal to the parameter estimates were assigned
to each disease retained in the multivariate model to cre-
ate a single comorbidity index variable for each outcome.
Using the validation samples, the predictive validity of
the MDS-based comorbidity indexes was determined and
compared to other measures of comorbidity (Charlson
Index [ChI], Chronic Disease Score [CDS], count of dis-
eases) as well as to Morris’ activities of daily living (ADL)
index for each outcome.
RESULTS: The MDS-based mortality index included
weighted variables for atherosclerotic heart disease (ASHD),
dysrhythmias, congestive heart failure (CHF), respiratory
disease and depression and had a c-statistic of 0.62 in the
development sample, and 0.60 in both validation samples.
Similar c-statistics were found for the comparison of co-
morbidity and functional status measures. The c-statistics
for the MDS-based hospitalization index (with weighted
variables for hemiplegia, glaucoma, peripheral vascular
disease (PVD), CHF, diabetes and hypertension) were 0.66
and 0.59 for the development sample and validation sam-
ple respectively and were similar to those found for the
other measures.
CONCLUSIONS: Presence or absence of diseases mea-
sured at baseline are weakly predictive of subsequent
hospitalization or mortality in this cohort. Additional pa-
tient risk factors such as disease severity, or change in
functional status should be investigated in future research
aimed at defining risk adjustment methods in this popu-
lation.
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OBJECTIVE: Health-related quality of life (HRQOLs)
are important health-status indicators. The longitudinal
aspect of transitions in HRQOL is not well known. This
study examines how HRQOL changes over time using a
Markov probability model.
METHOD: We analyzed 10,492 elderly persons aged 65
years or older and followed from 1991 to 1994 in MCBS,
a nationally representative sample of the US elderly pop-
ulation. We measured HRQOL by global health percep-
tion, Katz Index of Activities of Daily Living (ADL), and
Instrumental Activities of Daily Living (IADL). We esti-
mated the probability of transition from one state of
HRQOL to another using a Markov probability model.
We investigated the transition matrix of HRQOL by in-
corporating the competing risk of death and socio-demo-
graphic variables including age, race, gender and the in-
teraction terms among them.
RESULTS: Including death as a worst outcome, 1411
persons (13%) had a steady deterioration in global health
perception in the four-year time period. One thousand
one hundred six (1106) (11%) had steady improvement
of health perception, 1047 (10%) had a constant state,
and 6928 (66%) experienced fluctuations in health per-
ception. Similar patterns were found in ADL and IADL
measures. The transition probabilities for a female with a
base age of 70 indicated that one had 34% to 44%
chance of remaining in the same state of general health,
while the probability steadily decreases as the health per-
ception decreases. A male aged 70 years has a probability
of 32% to 53% to remain at the same state. As HRQOL
decreases by one unit, the probability of death increases
steadily from less than 1% to 12% for a female and from
5% to 21% for a male across all HRQOL measures.
CONCLUSION: The study shows the patterns in transi-
tion of HRQOL in the elderly population. The probabili-
ties of transition in three measures of HRQOL are gener-
ally consistent and interpretable.
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OBJECTIVES: This analysis presents trends in the
health-related quality of life of the US population from
1984 to 1994 and examines the hypothesis that fluctua-
tions in population health levels are related to changes in
economic status.
METHODS: Data on health status and quality of life as
well as personal and household characteristics are from
the US National Health Interview Survey and the US Vi-
tal and Health Statistics System. To examine the relation-
ship between health and economic well being, these data
are linked to economic data, including medical care in-
puts.
RESULTS: Health-related quality of life and quality-ad-
justed life years rose from 1984 to 1990 and declined af-
ter this period. Specifically, for the total population,
quality-adjusted life years rose from 63.4 in 1984 to 64.5
years in 1990 and declined to 64.0 in 1994. Similar pat-
terns were observed across genders and ethnic subgroups.
The changes in quality of life and mortality coincided
with periods of economic growth and recession over the
same interval. Regression analyses indicate that per cap-
ita income levels and unemployment rates are important
